SPR Therapeutics
SPR Therapeutics, Inc. is a Cleveland, Ohio medical device company that develops and commercializes the SPRINT Peripheral Nerve Stimulation (PNS) System, a non-opioid, minimally invasive percutaneous therapy for chronic and acute pain. SPRINT is the only percutaneous PNS device FDA-cleared for both chronic and acute pain that does not require permanent implantation: leads are placed in an outpatient procedure without surgery, incisions or anesthesia and deliver up to 60 days of therapy. The company was acquired by Medtronic plc on 2026-07-16 for $650 million and now operates within the Medtronic Neuromodulation Operating Unit. SPR is a device manufacturer rather than a software vendor: it publishes no public API, developer portal, SDK or machine-readable contract. Its only software surfaces are the consumer SPRINT PNS Patient App and the credentialed SPRcare provider reimbursement portal, neither of which exposes a public integration.
SPR Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Healthcare, Neuromodulation, and Pain Management.
SPR Therapeutics’ developer surface includes support, engineering blog, and 5 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.